Search Saint Luke's

TAVR in asymptomatic and minimally symptomatic patients is associated with a high survival rate, but relatively minor improvements, according to new research.

Rehospitalization after aortic valve replacement (AVR) is associated with an increased risk of patient mortality, according to new research.

The study shows that the diabetes and weight loss drug semaglutide significantly reduced symptoms and improved quality of life in people with obesity and the most common form of heart failure in a clinical trial.

Survival rates for Black women are far worse after bystander CPR than for white men, according to a study published this month.

The popular weight loss drug Wegovy seems to provide more health benefits for people who have diabetes and a common kind of heart failure than just helping take off the pounds, according to the results from the STEP HFpEF DM trial.

The diabetes and weight loss drug semaglutide significantly reduced symptoms and improved quality of life in people with obesity and the most common form of heart failure in a clinical trial.

Consumer Reports On Health talked to Dr. Bethany Austin and Austin Workman about strategies to improve quality of life for those living with heart failure.

Veteran news reporter Dan Verbeck missed the biggest story of his life—his own death.

Dr. Mikhail Kosiborod presented on the benefits of a cardiometabolic center of excellence for patients with cardiometabolic diseases at the ADA conference in San Diego.

Kelly Anspaugh received both a heart and kidney transplant at Saint Luke's.